Literature DB >> 18852483

Prevalence of monoclonal gammopathy of undetermined significance/myeloma in patients with acute osteoporotic vertebral fractures.

Terry Golombick1, Terry Diamond.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18852483     DOI： 10.1159/000162282

Source DB:  PubMed          Journal:  Acta Haematol        ISSN： 0001-5792            Impact factor:   2.195


× No keyword cloud information.
  12 in total

Review 1.  The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network.

Authors:  Niels W C J van de Donk; Antonio Palumbo; Hans Erik Johnsen; Monika Engelhardt; Francesca Gay; Henrik Gregersen; Roman Hajek; Martina Kleber; Heinz Ludwig; Gareth Morgan; Pellegrino Musto; Torben Plesner; Orhan Sezer; Evangelos Terpos; Anders Waage; Sonja Zweegman; Hermann Einsele; Pieter Sonneveld; Henk M Lokhorst
Journal:  Haematologica       Date:  2014-03-21       Impact factor: 9.941

2.  Use of trabecular bone score for risk stratification of patients with monoclonal gammopathy of undetermined significance.

Authors:  Jad G Sfeir; Tito D Pena Guzman; Lucia Bedatsova; Stephen M Broski; Matthew T Drake
Journal:  Bone       Date:  2020-04-28       Impact factor: 4.398

Review 3.  unveiling skeletal fragility in patients diagnosed with MGUS: no longer a condition of undetermined significance?

Authors:  Matthew T Drake
Journal:  J Bone Miner Res       Date:  2014-12       Impact factor: 6.741

4.  Bone disease in monoclonal gammopathy of undetermined significance: results from a screened population-based study.

Authors:  Sigrun Thorsteinsdottir; Sigrun H Lund; Ebba K Lindqvist; Marianna Thordardottir; Gunnar Sigurdsson; Rene Costello; Debra Burton; Hlif Steingrimsdottir; Vilmundur Gudnason; Gudny Eiriksdottir; Kristin Siggeirsdottir; Tamara B Harris; Ola Landgren; Sigurdur Y Kristinsson
Journal:  Blood Adv       Date:  2017-12-21

Review 5.  Bone disease from monoclonal gammopathy of undetermined significance to multiple myeloma: pathogenesis, interventions, and future opportunities.

Authors:  Alex R Minter; Haley Simpson; Brendan M Weiss; Ola Landgren
Journal:  Semin Hematol       Date:  2011-01       Impact factor: 3.851

Review 6.  Monoclonal gammopathy of undetermined significance and bone health outcomes: a systematic review and exploratory meta-analysis.

Authors:  Nicola Veronese; Claudio Luchini; Marco Solmi; Giuseppe Sergi; Enzo Manzato; Brendon Stubbs
Journal:  J Bone Miner Metab       Date:  2017-02-27       Impact factor: 2.626

7.  Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study.

Authors:  Sigurdur Y Kristinsson; Min Tang; Ruth M Pfeiffer; Magnus Björkholm; Cecilie Blimark; Ulf-Henrik Mellqvist; Anders Wahlin; Ingemar Turesson; Ola Landgren
Journal:  Blood       Date:  2010-07-07       Impact factor: 22.113

8.  Bone microstructural changes revealed by high-resolution peripheral quantitative computed tomography imaging and elevated DKK1 and MIP-1α levels in patients with MGUS.

Authors:  Alvin C Ng; Sundeep Khosla; Natthinee Charatcharoenwitthaya; Shaji K Kumar; Sara J Achenbach; Margaret F Holets; Louise K McCready; L Joseph Melton; Robert A Kyle; S Vincent Rajkumar; Matthew T Drake
Journal:  Blood       Date:  2011-10-31       Impact factor: 22.113

9.  Bone tissue quality in patients with monoclonal gammopathy of uncertain significance.

Authors:  Guillermina Orduna; Leonardo Mellibovsky; Eugenia Abella; Xavier Nogués; Roser Granero; Natalia García-Giralt; Marta Pineda-Moncusí; Roberto Güerri-Fernández; Daniel Prieto-Alhambra; Adolfo Díez-Pérez
Journal:  J Bone Miner Metab       Date:  2020-01-23       Impact factor: 2.626

10.  Disrupted radial and tibial microarchitecture in patients with monoclonal gammopathy of undetermined significance.

Authors:  E M Stein; A Dash; M Bucovsky; S Agarwal; J Fu; S Lentzsch; E Shane
Journal:  Osteoporos Int       Date:  2018-11-28       Impact factor: 4.507
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.